These data demonstrate that elevated ZEB1 and CDH2, as well as reduced CDH1, portend worse clinical outcomes in MM, and that combined assessment of KPC1, ZEB1 and CDH2 expression can further improve prognostic precision. Here, ZEB1 is linked to Miyoshi myopathy.